Μεταβολική έρευνα

Metabolic research peptides include GLP-1 receptor agonists and multi-pathway compounds studied for glucose regulation, appetite signaling, and systemic energy metabolism. This category focuses on incretin-based analogues used in metabolic and endocrine research models.

Key compounds in this category include Semaglutide, Tirzepatide, and Retatrutide, representing single, dual, and triple agonist approaches to metabolic pathway investigation. Semaglutide is a long-acting GLP-1 receptor agonist, while Τιρζεπατίδη activates both GLP-1 and GIP receptors. Ρετατρουτίδη extends this mechanism further by engaging GLP-1, GIP, and glucagon receptors.

Explore Ρετατρουτίδη, Τιρζεπατίδη, και Semaglutide, or browse related categories such as αυξητική ορμόνη εκκριγωγόνα for complementary research compounds.

All products are supplied in lyophilized form and are intended for laboratory and analytical research purposes only.

For a detailed comparison of GLP-1, dual, and triple agonists, see our complete Οδηγός μεταβολικής έρευνας GLP-1.